| Aug 9 |
Belite Bio EPS of -$0.31 misses by $0.05
|
| Aug 9 |
Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
|
| Aug 8 |
Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
|
| Aug 5 |
Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results
|
| Jul 8 |
Belite Bio to Present at the JonesHealthcare Seaside Summit
|
| Jun 17 |
Estimating The Intrinsic Value Of Belite Bio, Inc (NASDAQ:BLTE)
|
| Jun 12 |
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
|
